China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China flag China · Delayed Price · Currency is CNY
28.88
+0.17 (0.59%)
Feb 27, 2026, 3:04 PM CST

SHE:000999 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
-5,0176,7713,1503,065
Trading Asset Securities
-1,6771,456-1,219
Cash & Short-Term Investments
8,5756,6948,2273,1504,284
Cash Growth
28.10%-18.63%161.19%-26.48%6.45%
Accounts Receivable
-8,8907,9465,6445,419
Other Receivables
-48.2956.5614.0279.28
Receivables
-8,9388,0035,6585,498
Inventory
-4,9335,1122,4992,369
Other Current Assets
-1,3111,180681.97527.57
Total Current Assets
-21,87622,52211,98812,679
Property, Plant & Equipment
-6,6046,6144,8164,263
Long-Term Investments
-1,203643.122,913238.69
Goodwill
-5,1245,1243,9954,060
Other Intangible Assets
-3,3783,4572,3692,297
Long-Term Deferred Tax Assets
-643.3626.81324.5242.1
Long-Term Deferred Charges
-897.04788.34509.29467.08
Other Long-Term Assets
-356.6373.28207.33295.37
Total Assets
-40,08240,14827,12324,542
Accounts Payable
-3,1493,0971,7951,499
Accrued Expenses
-4,8684,5693,6663,215
Short-Term Debt
-855.57885.65168.590.04
Current Portion of Long-Term Debt
-81.1793.4210.76-
Current Portion of Leases
-78.5178.650.1245.47
Current Income Taxes Payable
-374.34254.47110.6168.15
Current Unearned Revenue
-1,8611,6501,0121,476
Other Current Liabilities
-2,3382,3181,8591,453
Total Current Liabilities
-13,60512,9478,6737,947
Long-Term Debt
-177.941,82150.227.97
Long-Term Leases
-91.95119.51105.8288.71
Long-Term Unearned Revenue
-449.16455.5423.19395.13
Pension & Post-Retirement Benefits
---82.8989.37
Long-Term Deferred Tax Liabilities
-343.29340.79217.75198.88
Other Long-Term Liabilities
-157.99202.8836.840.19
Total Liabilities
-14,82615,8879,5898,767
Common Stock
-1,284988.18988.35978.9
Additional Paid-In Capital
-1,8631,8781,7971,644
Retained Earnings
-16,76316,16214,29712,690
Treasury Stock
--70.74-131.98-143.57-
Comprehensive Income & Other
-63.1771.2670.590.22
Total Common Equity
21,11619,90318,96717,01015,313
Minority Interest
-5,3535,295523.78461.28
Shareholders' Equity
37,37925,25624,26217,53315,774
Total Liabilities & Equity
-40,08240,14827,12324,542
Total Debt
5,4891,2852,998385.42232.18
Net Cash (Debt)
3,0865,4095,2292,7644,052
Net Cash Growth
-42.95%3.45%89.15%-31.78%1.31%
Net Cash Per Share
1.863.253.141.662.45
Filing Date Shares Outstanding
1,6641,6701,6701,6701,654
Total Common Shares Outstanding
1,6641,6701,6701,6701,654
Working Capital
-8,2709,5753,3164,732
Book Value Per Share
12.6911.9211.3610.189.26
Tangible Book Value
8,23211,40110,38710,6458,956
Tangible Book Value Per Share
4.956.836.226.375.41
Buildings
-5,4925,1223,4593,419
Machinery
-4,9134,5443,6213,361
Construction In Progress
-306.72537.8946.09407.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.